| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – | – |
| R&D | – | $22.82M | $15.81M | $30.08M | $23.97M | $5.64M |
| SG&A | – | $16.25M | $11.44M | $10.72M | $9.13M | $2.34M |
| Operating Income | – | – | – | – | – | – |
| Interest Expense | – | – | $2.85M | $1.79M | – | – |
| Tax Expense | – | – | – | – | – | – |
| Net Income | -$54.65M | -$39.83M | -$29.82M | -$42.35M | -$33.15M | -$8.00M |
| EPS (basic) | -1.2500 | -1.2400 | -1.5000 | -4.0000 | -4.0800 | – |
| EPS (diluted) | -1.2500 | -1.2400 | -1.5000 | -4.0000 | -4.0800 | – |
| Shares (diluted) | $43.59M | $32.07M | $19.83M | $10.59M | $8.12M | – |